Benjamin Hickey
Förmögenhet: 1 M $ per 2026-07-31
Förmögenhet: 1 M $ per 2026-07-31
Benjamin Joseph Hickey is Director at Bristol-Myers Squibb Holdings 2002 Ltd. since 2016 and President at Rayzebio, Inc. since 2024.
Former roles include Independent Director at Surface Oncology, Inc. from 2021 to 2023, Director at Bristol-Myers Squibb Pharmaceuticals Ltd. from 2016 to 2018, Independent Director at Mural Oncology Plc from 2023 to 2025, Chief Commercial Officer & Senior Vice President at Halozyme Therapeutics, Inc. from 2018 to 2020, Chief Commercial Officer at Mirati Therapeutics, Inc. from 2020 to 2024, and Vice President-Marketing at Bristol Myers Squibb Co. from 2014 to 2016.
Education includes undergraduate and MBA degrees from St. John's University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-10 | 16 672 ( 0 % ) | 1 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| RAYZEBIO, INC. | President | 2024-02-26 |
Bristol-Myers Squibb Holdings 2002 Ltd.
Bristol-Myers Squibb Holdings 2002 Ltd. Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries distributes and sells pharmaceutical products | Direktör/Styrelseledamot | 2016-08-01 |
| Företag | Position | Slut |
|---|---|---|
| MIRATI THERAPEUTICS | Företagsledare/Principal | 2024-01-23 |
| SURFACE ONCOLOGY, INC. | Direktör/Styrelseledamot | 2023-09-08 |
| HALOZYME THERAPEUTICS, INC. | Företagsledare/Principal | 2020-01-01 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktör/Styrelseledamot | 2018-09-03 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
St. John's University
St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Holdings 2002 Ltd.
Bristol-Myers Squibb Holdings 2002 Ltd. Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries distributes and sells pharmaceutical products | Distribution Services |
Surface Oncology, Inc.
Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Rayzebio, Inc.
Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån